Literature DB >> 8605277

Light chain-restricted autoantibodies in chronic idiopathic thrombocytopenic purpura, but no evidence for circulating clone B-lymphocytes.

D Stockelberg1, M Hou, S Jacobsson, J Kutti, H Wadenvik.   

Abstract

In chronic idiopathic thrombocytopenic purpura (ITP) platelet destruction is caused by antibodies directed against platelet membrane glycoproteins (GP), and the predominant autoantigens are known to be GPIb/IX and GPIIb/IIIa. In a recent study we reported that these antibodies frequently had a restricted light chain phenotype, thereby supporting a clonal origin. Similar findings and the presence of clonal B-cell populations in immune thrombocytopenias have been reported by others. In the present study we further explored the hypothesis of clonal B-cell expansions in chronic ITP. Twenty patients with chronic ITP were investigated. Antibodies were detected with an ELISA (MAIPA) specific for GPIb/IX and GPIIb/IIIa; circulating clonal B lymphocytes were assessed by flow-cytometric (FACS) clonal-excess analysis and by analyzing Ig-gene rearrangements (CDR3) with the PCR technique. Nine patients displayed a GP-specific antibody restricted to either kappa or lambda phenotype. However, FACS analysis and Ig-gene rearrangement studies did not disclose any circulating clonal B-cell population. Considering the sensitivity of the FACs analysis and Ig-gene rearrangement for detection of clonal B-cell populations, the hypothesis of clonally derived autoantibodies in ITP is still valid. Most probably, the clonal B-cell expansion responsible for the production of autoantibodies in ITP, if present, is below the detection limit for the techniques employed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605277     DOI: 10.1007/bf00663013

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  35 in total

1.  Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura.

Authors:  V Kiefel; S Santoso; E Kaufmann; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

2.  Monoclonality in B-lymphoproliferative disorders detected at the DNA level.

Authors:  K J Trainor; M J Brisco; C J Story; A A Morley
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

3.  T-cell abnormalities in patients with idiopathic thrombocytopenic purpura: the presence of OKT4+8+ cells.

Authors:  H Mizutani; S Katagiri; K Uejima; M Ohnishi; T Tamaki; Y Kanayama; T Tsubakio; Y Kurata; T Yonezawa; S Tarui
Journal:  Scand J Haematol       Date:  1985-08

4.  T-cell subsets defined by monoclonal antibodies in autoimmune thrombocytopenic purpura (ATP).

Authors:  F Lauria; D Raspadori; M Gobbi; A Guarini; L Gugliotta; M Aieta; S Tura
Journal:  Haematologica       Date:  1983 Sep-Oct       Impact factor: 9.941

5.  Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura.

Authors:  D van der Harst; D de Jong; J Limpens; P M Kluin; Y Rozier; G J van Ommen; A Brand
Journal:  Blood       Date:  1990-12-01       Impact factor: 22.113

6.  Incidence of autoantibodies to GPIIb/IIIa in chronic autoimmune thrombocytopenic purpura may be overestimated by the MAIPA.

Authors:  J Hewitt; I E Burton
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

7.  Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.

Authors:  D Billadeau; M Blackstadt; P Greipp; R A Kyle; M M Oken; N Kay; B Van Ness
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

8.  Differences in T cell subsets between men and women with idiopathic thrombocytopenic purpura.

Authors:  R Mylvaganam; Y S Ahn; W J Harrington; C I Kim; H G Gratzner
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

9.  Detection of clonal platelet antibodies in immunologically-mediated thrombocytopenias: association with circulating clonal/oligoclonal B cells.

Authors:  D J Christie; S C Sauro; K D Fairbanks; N E Kay
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

10.  Immunoregulatory defect in patients with autoimmune thrombocytopenic purpura (ATP).

Authors:  S Peller; S Kaufman; U Shaked
Journal:  Thymus       Date:  1986
View more
  2 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Emerging Concepts in Immune Thrombocytopenia.

Authors:  Maurice Swinkels; Maaike Rijkers; Jan Voorberg; Gestur Vidarsson; Frank W G Leebeek; A J Gerard Jansen
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.